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Abstract
Adenine (ADE) reutilisation is an important pathway of adenylate pool regeneration. Data on the rate of this process in
different types of cells, its regulation and the importance of species differences is limited. In this study we evaluated adenine
incorporation rate and the effect of metabolic factors on this process in human and rat endothelium and compared it to
adenine phosphoribosyltransferase (APRT) activity. Microvascular endothelial cells from human (HE) and rat (RE) hearts
and a transformed human microvascular endothelial cell line (HMEC-1) were investigated. The rate of adenine incorporation
into the adenine nucleotide pool under control conditions was 3.1 þ 0.3, 82.8 þ 11.1 and 115.1 þ 11.2 pmol/min per mg protein
for HE, RE and HMEC-1, respectively. In the presence of 2.5 mM ribose or elevated inorganic phosphate concentration in
the medium (4.8 mM), few changes were observed in all types of cells. In the presence of both ribose and high inorganic
phosphate, the rate of adenine incorporation for RE and HMEC-1 was not significantly different from control, while in HE
the rate of adenine incorporation into adenine nucleotides was increased by 75%. Activities of APRT in RE and HMEC-1
were 237.7 þ 23.2 and 262.0 þ 30.6 pmol/min per mg protein respectively while the activity in HE was markedly lower
48.7 þ 3.0 pmol/min per mg protein. In conclusion, nucleotide synthesis from adenine seems to be a slow process in human
cardiac microvascular endothelium but it is fast and efficient in rat heart microvascular endothelial cells. Low APRT activity
in normal human endothelial cells seems to be the most likely mechanism for this. However, adenine incorporation rate and
APRT activity could be greatly enhanced in human endothelium, as demonstrated in transformed cells. ß 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Adenine (ADE) reutilisation is an important path-
way of adenylate pool regeneration. Although the
maximal rate of adenine phosphoribosylation is
lower than adenosine phosphorylation in the heart, it
is much faster than purine synthesis de novo or ad-
enine nucleotide synthesis from hypoxanthine [1].
Adenine incorporation requires phosphoribosylpyro-
phosphate (PRPP). Endogenous PRPP synthesis is
dependent on the pentose phosphate pathway but,
alternatively, it could be produced from an exoge-
nous supply of ribose. The presence of ribose was
found to increase ATP synthesis in the heart together
with enhancement of mechanical recovery after car-
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dioplegia and ischaemia [2^4] but it has not been
identi¢ed which types of cells are important in this
process. The enzyme responsible for PRPP produc-
tion, PRPP synthetase, is strongly activated by inor-
ganic phosphate [5], which could be important in
increasing the supply of PRPP for adenine reutilisa-
tion.
It has been shown that the adenine nucleotide pool
size is exceptionally high in endothelial cells but the
importance of this phenomenon for the function of
endothelial cells is uncertain [6]. Endothelial ATP
and nucleotide pool could be important not only
for maintenance of cell viability but also for the
physiological function of these cells. A mechanism
for nucleotide release from endothelial cells has
been demonstrated [7] which could be involved in
the control of thrombosis and in£ammation. Extra-
cellular ATP was found to a¡ect a number of meta-
bolic and regulatory processes through several types
of purinergic receptors [8]. Nucleotide levels could be
important also in cytoprotective mechanisms, such as
adenosine production. Although the contribution of
endothelial cells for adenosine production is small
under ischaemic conditions, this proportion under
normoxia is considerable [9,10]. We have shown pre-
viously the association between nucleotide pool and
adenosine production in perfused heart and in iso-
lated cardiomyocytes [11,12].
The aim of the present study was the evaluation of
the rate, concentration dependence and the activity
of the enzyme responsible for adenine incorporation
into the adenylate pool in human and rat capillary
endothelium and in transformed human microvascu-
lar cell line. Furthermore, the e¡ects of ribose and
increased inorganic phosphate concentration on this
process were studied in detail.
2. Materials and methods
2.1. Endothelial cell isolation and culture
All animals received humane care in compliance
with the Guide for the Care and Use of Laboratory
Animals published by the National Institutes of
Health (NIH publication no. 85-23, revised 1985).
Rat endothelial cells were cultured after collagenase
digestion of the heart according to the procedure
described by Piper et al. [13] as described in detail
previously [11]. Endothelial cells were separated from
cardiomyocytes by centrifugation and were plated
initially in 6-cm diameter plastic culture dishes and
then after 2^3 passages transferred into 3.5-cm diam-
eter dishes. Human tissue was used in accordance
with the ethical standards as formulated in the Hel-
sinki Declaration of 1975 (revised in 1983).
Human endothelial cells were isolated from the left
ventricle from the explanted heart. The method of
McDouall et al. [14] was followed. Brie£y, epicardi-
um and endocardium were discarded to minimise
contamination by other cell types, the tissue was di-
gested with collagenase and endothelial cells were
isolated by positive selection on HLA-DR and
Ulex-coated Dynabeads.
Human derived endothelial cell line (HMEC-1)
used in another series of experiments were obtained
from human dermal microvascular cells transfected
with the simian virus 40 large T antigen. This cell line
has been shown immunologically to retain the char-
acteristics of normal human microvascular endothe-
lial cells [15]. Cultures of endothelial cells were used
for experiments after reaching con£uence.
2.2. Experimental protocol for measurement of
adenine incorporation
Firstly, incubation medium was removed and re-
placed by Hank’s balanced salt solution (HBSS).
After two subsequent changes of HBSS, a ¢nal vol-
ume of 1.2 ml was added and the experiment was
started. The initial pre-incubation time was 30 min
after which [8-14C]adenine was added at a concentra-
tion varying from 0.3 WM to 0.3 mM as indicated.
Ribose was added or inorganic phosphate concentra-
tion increased for the entire 30 min of pre-incuba-
tion. Incubation with adenine was carried out for
10 min (for human cells) or for 5 min (for rat cells).
At the end of the incubation, the medium was col-
lected and 0.6 ml of cold 0.4 M HClO4 added to the
incubation dish to extract cellular nucleotides. Acid
extracts were centrifuged and neutralised with 2 M
KOH followed by centrifugation. Supernatants were
subjected to further analysis by HPLC as described
below. Protein concentration was evaluated using the
Bradford method [16] after dissolving the perchloric
acid precipitates with 0.5 M NaOH.
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2.3. Adenine phosphoribosyltransferase (APRT)
assay procedure
Cell homogenates for enzyme assay were prepared
from con£uent endothelial cells grown in 25-cm2
£asks. Culture media was removed and cells were
washed three times with phosphate-bu¡ered saline
(PBS). Homogenisation bu¡er containing 150 mM
KCl, 20 mM Tris, 1 mM EDTA, 1 mM dithiothreitol
(pH 7.0) plus 0.1% Triton X-100 (0.1 ml) was added
in three portions to maximise cell recovery. Endothe-
lial cell homogenates were diluted with incubation
bu¡er before assay. The incubation bu¡er consisted
of 50 mM imidazole and 10 mM MgCl2 (pH 7.0).
The reaction was initiated by the addition of 20 Wl of
diluted cell extract to an equal volume of substrate
solution, incubated at 37‡C for 10 min and termi-
nated by the addition of 20 Wl of 1.3 M HClO4.
The substrate solution contained 8 mM PRPP,
200 WM methylene adenosine 5P-diphosphate
(AOPCP), 200 WM [8-14C]adenine with a speci¢c ac-
tivity of 12.5 WCi/Wmol, all dissolved in incubation
bu¡er. For blanks, perchloric acid was added to the
substrate solution prior to the addition of cell ex-
tract. Samples were neutralised with 7 Wl of 3 M
K3PO4 and centrifuged at 13 000 rpm for 3 min.
The resultant supernatant was analysed for conver-
sion of substrate to products by collection of radio-
active peaks separated by reverse-phase HPLC [17].
The reaction was linear with respect to the amount
of cellular protein and the incubation time for all the
di¡erent cell types.
2.4. Nucleotide, nucleoside and base analysis by
HPLC
All determinations of metabolite concentrations
were performed using high-performance liquid chro-
matography (HPLC). The equipment used was
Merck^Hitachi chromatograph linked to 1050 series
diode array detector (Hewlett^Packard) and type
507A on-line radiodetector (Berthold). Radioactive
peaks of ATP/ADP and AMP collected from the
APRT assay were counted using a Packard 1600-
TR liquid scintillation analyser to determine the ex-
tent of adenine incorporation. The reversed-phase
method used for determination of ATP, ADP,
AMP, adenosine, inosine, hypoxanthine, xanthine,
uric acid in the incubation medium, cell extracts
and APRT enzyme reaction has been described in
detail previously [17,18].
2.5. Statistical analysis
Values are presented as mean þ standard error of
the mean (S.E.M.). Statistical comparison of di¡er-
ent groups was performed using one-way analysis of
variance (parametric or non-parametric Kruskal^
Wallis test where appropriate) followed by Dunn’s
test. A value of P6 0.05 was considered as a signi¢-
cant di¡erence.
3. Results
Fig. 1 shows the relationship between the time and
the amount of adenine incorporated into the nucleo-
tide pool of rat endothelial cells at 10 WM adenine
concentration in the medium. As may be seen, the
relationship was linear for up to 30 min of incuba-
tion. Fig. 2 demonstrates the concentration e¡ect of
adenine in the incubation medium and the amount
incorporated into the rat endothelial nucleotide pool.
The data demonstrates that adenine incorporation is
a high a⁄nity process with half saturation constant
of about 0.5 WM.
Adenine incorporation under normal physiological
Fig. 1. Adenine incorporation into nucleotide pool in rat endo-
thelium at di¡erent times of incubation. Cell cultures were incu-
bated in the presence of 10 WM [14C]adenine at 37‡C in Hank’s
balanced salt solution (HBSS) for the time indicated. Values
are the mean of duplicate experiments.
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concentration of phosphate and pH in rat, human
and HMEC-1 endothelium is presented in Fig. 3.
The rate observed in human microvascular cells
was 25^35 times lower than in rat or in human trans-
formed endothelium. The e¡ect of di¡erent concen-
trations of ribose on adenine incorporation into the
nucleotide pool of rat endothelial cells was evaluated
within the concentration range 0.1 mM to 2.5 mM.
No e¡ect on adenine incorporation was observed
(changes were less than 15% from control value).
At 2.5 mM ribose adenine incorporation rate was
89.7 þ 12.5 pmol/min per mg protein as compared
to 82.8 þ 11.1 pmol/min per mg protein without ri-
bose under control conditions. The e¡ect of inor-
ganic phosphate on adenine incorporation into rat
endothelial cells was evaluated within the concentra-
tion range of 0.5 to 4.8 mM. An increase in inorganic
phosphate concentration exerted only a little e¡ect
on the rate of adenine incorporation (less than 20%
di¡erence from the control value). At 4.8 mM inor-
ganic phosphate, adenine incorporation increased to
117.3 þ 14.0 pmol/min per mg protein. In the pres-
ence of both ribose and high inorganic phosphate,
the rate of adenine incorporation was still not signi¢-
cantly di¡erent from control (112.4 þ 31.8 pmol/min
per mg protein).
In human heart microvascular endothelial cells,
the presence of 2.5 mM ribose exerted no e¡ect
and the rate was 3.0 þ 0.4 pmol/min per mg protein
as compared to 3.1 þ 0.3 pmol/min per mg protein
without ribose under control conditions. In the pres-
ence of both ribose and 4.8 mM inorganic phos-
phate, the rate of adenine incorporation was in-
creased to 5.5 þ 0.5 pmol/min per mg protein
(P6 0.05 vs. no ribose and phosphate).
In human microvascular cell line the presence of
ribose did not exert any e¡ect on the incorporation
rate of adenine. The rate with 2.5 mM ribose was
117.9 þ 7.5 pmol/min per mg protein as compared
to 115.1 þ 11.2 pmol/min per mg protein without
ribose under control conditions. In the presence of
2.5 mM ribose and 4.8 mM inorganic phosphate the
Fig. 4. Adenine phosphoribosyl transferase (APRT) activity in
microvascular endothelial cells isolated from the rat and human
heart and in a transformed human microvascular endothelial
cell line (HMEC-1). Values represent mean þ S.E.M., n = 6^10.
*P6 0.05 vs. rat endothelium and HMEC-1.
Fig. 3. Adenine incorporation rate in microvascular endothelial
cells isolated from the rat and human heart and in a trans-
formed human microvascular endothelial cell line (HMEC-1).
Values represent mean þ S.E.M., n = 5^6. *P6 0.05 vs. rat endo-
thelium and HMEC-1.
Fig. 2. Relation of adenine incorporation to its concentration
in rat endothelium. Cell cultures were incubated in the presence
of [14C]adenine at 37‡C in HBSS for 5 min. Values are mean þ
S.E.M., n = 4^6.
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rate was even lower than control (90.2 þ 8.4 pmol/
min per mg protein, P6 0.05 vs. no ribose and phos-
phate).
The APRT activity in human heart microvascular
endothelial cells was found to be ¢ve times lower
than in rat endothelial cells (Fig. 4). The activity
for HMEC-1 cells was found to be comparable to
the rate found in rat endothelial cells and again ¢ve-
fold greater than the rate for normal human micro-
vascular endothelial cells.
4. Discussion
This study demonstrated prominent di¡erences in
adenine incorporation rate between human and rat
heart microvascular endothelial cells and between
primary cultured human cells and transformed cell
line. Adenine incorporation rate in human cells was
only about 3% of the rate in rat endothelium. On the
other hand, the transformed human microvascular
endothelial cell line demonstrated a markedly in-
creased adenine incorporation. Our measurements
of APRT activity in the di¡erent cell types indicates
that these di¡erences could result from low activity
of APRT in normal human cells. Nucleotide synthe-
sis from adenine is thus ine⁄cient in normal human
endothelium, and an attempt to accelerate adenine
incorporation in human endothelium could be bene-
¢cial for cell metabolism and function following ox-
idative stress or ischaemia which would result in nu-
cleotide pool depletion.
Adenine reutilisation rate may be a¡ected not only
by APRT activity, but also by a number of other
factors such as PRPP supply and membrane adenine
transport. Our ¢ndings presented here, along with
those of other authors, show large discrepancies be-
tween the activity of APRT measured in homoge-
nates and the actual rate of reutilisation in intact
cell models [19,20]. Membrane transport rate of ad-
enine does not seem to be a limiting step of this
process [21,22]. In erythrocytes and cardiomyocytes
adenine reutilisation could be accelerated several-fold
by the addition of ribose, a substrate for PRPP syn-
thesis [2,19,23]. However, our study demonstrated
that a supply of ribose or increasing phosphate con-
centration did not increase the rate of adenine reuti-
lisation in rat endothelium. It is possible that this is
the result of a high £ux through the pentose phos-
phate pathway in endothelial cells and optimal sup-
ply of ribose moiety for nucleotide synthesis. The
other factor which may a¡ect the rate of adenine
incorporation is inorganic phosphate, which is a po-
tent activator of PRPP synthetase [5]. No changes in
adenine nucleotide synthesis in rat endothelium with
increased inorganic phosphate in the medium sug-
gests a high £ux through this reaction under baseline
conditions, which is capable of providing an optimal
supply for adenine reutilisation. Consequently, the
concentration of adenine was in fact the only factor
which controlled the rate of adenine incorporation in
rat endothelial cells. It appears from the relation be-
tween adenine concentration and the rate of adenine
incorporation presented in this study that the a⁄nity
is very high, comparable to the kinetic properties of
the isolated enzyme [24].
Comparison of the rate of adenine reutilisation in
endothelium reported in this study with the data
published for cardiomyocytes [19] suggests that the
rate under baseline conditions is much lower in car-
diomyocytes than in endothelium. However, it has
been shown that the addition of ribose caused an
acceleration of adenine reutilisation in cardiomyo-
cytes [11]. Consequently, with a supply of ribose,
the rate could be similar in rat cardiomyocytes and
endothelial cells.
In the present study, the rate of adenine reutilisa-
tion in human microvascular endothelial cells was
25 times smaller and the APRT activity was ¢ve
times smaller than in rat endothelium. No e¡ect of
ribose was seen, this is in accordance with a previous
study where adenine incorporation was evaluated in
human vein endothelial cells [25]. Unlike in the rat
endothelium, some increase in adenine incorporation
was observed in the presence of ribose and phos-
phate in human microvascular cells, suggesting that
PRPP concentration is below optimum. This may be
responsible for the greater discrepancy between
APRT activity and the rate of adenine incorporation.
Adenine incorporation pathway was found to be
regulated in human cells, depending mainly on cell
growth rate. In rapidly dividing trophoblast cells iso-
lated from the ¢rst trimester placentas, the rate of
adenine incorporation was tenfold greater than in the
cells isolated in the third trimester [26]. This is in
accordance with our observations indicating that
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APRT activity and adenine incorporation rate is in-
creased in rapidly growing transformed human endo-
thelial cells. High APRT activity seems to be an iso-
lated di¡erence of nucleotide metabolism between
human microvascular cell and HMEC-1 cell line, as
we have not observed major di¡erences in adenosine
kinase or deaminase activities, purine nucleoside
phosphorylase activity, or AMP-deaminase activity
between both types of cells (unpublished observa-
tions). All types of cells were treated in a very similar
way under culture conditions so it is unlikely to be a
factor a¡ecting the di¡erences we observed. In addi-
tion, lactate dehydrogenase activity was comparable
in the rat and human cells (not shown). The mecha-
nism by which adenine incorporation could be in-
creased in the normal human endothelial cells is an
important challenge, since this would allow more ef-
¢cient regulation of the nucleotide pool in human
endothelial cells and all related physiological pro-
cesses.
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